Cuba’s National Regulatory Authority & COVID-19: Olga Lidia Jacobo-Casanueva MS Director, Center for State Control of Medicines and Medical Devices (CECMED)
2021; Volume: 23; Issue: 3-4 Linguagem: Inglês
10.37757/mr2021.v23.n3.3
ISSN1555-7960
AutoresTania L. Aguilar-Guerra, Esther María Fajardo Díaz, Conner Gorry,
Tópico(s)SARS-CoV-2 and COVID-19 Research
ResumoAt the time of this writing, more than 10 million Cubans (nearly 90% of the country’s population), had received at least their first dose of Soberana 02 or Abdala, two of five vaccine candidates for SARS-CoV-2 developed and produced on the island. Late-phase clinical trial data revealed that Abdala is 92.28% effective after the full, […]
Referência(s)